Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription

Wen Ling Wang, Yi Chao Lee, Wen Ming Yang, Wen Chang Chang, Ju Ming Wang

研究成果: 雜誌貢獻文章同行評審

36 引文 斯高帕斯(Scopus)


CEBPB, one of the CEBP family members, is a crucial regulator of gene expression during innate immunity, inflammatory responses and adipogenesis. In this study, the EGF-induced increase of CEBPB mRNA is shown to be coincident with the decrease of COX-2 mRNA. We identified that all of the individual CEBPB isoforms, LAP1, LAP2 and LIP, attenuate EGF-induced COX-2 promoter activity. Although increased sumoylation of both LAP1 and LAP2 is observed during the lagging stage of EGF treatment, only the sumoylated LAP1, but not the sumoylated LAP2, is responsible for COX-2 gene repression. In addition, EGF treatment can regulate the nucleocytoplasmic redistribution of HDAC4 and SUMO1. We further demonstrated by loss-of- and gain-of-function approaches that HDAC4 can be a negative regulator while inactivating COX-2 transcription. The sumoylation mutant LAP1, LAP1K174A, exhibits an attenuated ability to interact with HDAC4, and increased COX-2 promoter activity. Furthermore, the in vivo DNA binding assay demonstrated that LAP1K174A and CEBPDK120A, sumoylation-defective CEBPD mutants, attenuate the binding of HDAC4 on the COX-2 promoter. In light of the above, our data suggest that the suCEBPD and suLAP1 are involved in the repression of COX-2 transcription through the recruitment of HDAC4.

頁(從 - 到)6066-6079
期刊Nucleic Acids Research
出版狀態已發佈 - 2008

ASJC Scopus subject areas

  • 遺傳學


深入研究「Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription」主題。共同形成了獨特的指紋。